![]() |
市场调查报告书
商品编码
1627766
认知功能补充品市场:预测(2025-2030)Cognition Supplements Market - Forecasts from 2025 to 2030 |
全球认知功能补充剂市场预计复合年增长率为 13.79%,从 2025 年的 148.1 亿美元增长到 2030 年的 274.3 亿美元。
这些精神药物(认知补充剂)声称可以改善记忆力、注意力和整体大脑功能。咖啡因、银杏叶、假马齿苋和Omega-3脂肪酸是常见成分。
想要保持思维敏捷的老龄化人群对认知健康解决方案的需求正在推动认知补充剂市场的发展。压力水平上升、忙碌的生活方式以及阿兹海默症认知疾病的发生进一步推动了市场成长。证明特定物质有效性的研究和技术发展也有助于市场扩张。此外,随着人们越来越重视一般大脑健康和认知表现,预防保健和自我护理的趋势正在推动对认知补充剂的需求。
据世界卫生组织(WHO)称,世界人口正在迅速老化。到2020年,全球将有10亿人年龄超过60岁。到 2030 年,这个数字将增加到 14 亿,也就是地球上六分之一的人口。此外,到 2050 年,60 岁及以上的人口数量将翻一番,达到 21 亿。 2020年至2050年间,80岁及以上的人口数量预计将增加两倍,达到4.26亿。
此外,为了应对不断变化的消费者偏好,认知补充剂行业的市场公司正在投资创新配方的研究,建立策略伙伴关係关係以扩大分销范围,并使用品牌和行销技术等各种策略来吸引客户。
此外,基于临床和科学证据,Provi(R) Sensia 是一种新颖的益生菌理念,可以改善情绪和睡眠质量,改善工作记忆和学习,并促进认知能力的增强。这些大脑过程对于改善人们的整体心理健康至关重要。这种新的益生菌解决方案是在当地支持下量身定制的,可满足不同的消费者需求,并得到全球健康声明的支持。
总体而言,由于人口老化、认知健康意识增强以及对增强性能产品的需求增加等原因,认知功能补充剂市场正在显着扩大。市场参与企业采用各种策略,包括品牌宣传活动、策略联盟和研发,以在这个不断变化的环境中保持竞争力。此外,由于消费者偏好的变化以及技术进步开发更有效配方的能力,认知功能补充剂市场预计未来将会成长。
全球认知功能补充品市场的驱动因素
认知功能补充剂市场预计将受到精神疾病预期增加的显着推动。包括焦虑症、忧郁症和过动症在内的全球疾病盛行率不断上升,对增强心理健康的补充和替代方法提出了更大的需求。声称可以提升情绪、减轻压力和增强认知功能的补充剂称为认知补充剂,旨在满足这种需求。随着人们寻找预防和治疗心理健康问题的方法,认知功能补充品市场预计将在未来几年大幅扩张。这显示了该行业的创新和成长潜力。
据估计,到 2021 年,美国将有 5,780 万名 18 岁及以上的人患有 AMI。这个数字占所有美国成年人的 22.8%。女性 AMI 发生率 (27.2%) 高于男性 (18.1%)。 AMI 发生率在年轻人(18-25 岁)中最高(33.7%),其次是成年人(26-49 岁;28.1%)和老年人(15.0%)。
在具有两种或多种种族认同的成年人中,AMI 最常见 (34.9%),其次是美洲印第安人或阿拉斯加原住民 (AI/AN) 的人 (26.6%)。亚洲成年人的 AMI 发生率最低(16.4%)。
此外,在印度,政府实施了国家心理健康计划(NMHP),以提供方便且价格合理的心理保健设施。国家卫生使命向各州和首府支持地区心理健康计划 (DMHP),该计划是 NMHP 的组成部分,该计划已获核准在 704 个地区实施。 DMHP 为残障人士提供门诊病人服务、评估、咨询、社会心理干预、持续护理和支持、药物治疗以及社区健康中心 (CHC) 和初级卫生中心 (PHC) 层面的推广服务、救护车服务和其他服务。
此外,自我报告的精神和行为障碍是澳洲统计局 (ABS) 2020-2021 年国家健康调查 (NHS) 涵盖的众多健康问题之一。只有当该人声明该疾病已持续或预计将持续六个月或更长时间时,NHS 才会在收集期间将其记录为患有精神或行为障碍。根据 NHS 2020-2021 (ABS 2022b),五分之一 (20%) 15 岁及以上的澳洲人在收集期间(2020 年 8 月至 2021 年 6 月)存在精神或行为问题,推测患有残疾。
全球认知补充品市场的地理前景
老化是失智症和认知障碍的主要原因之一。美国老年人的数量正在稳定增加,导致失智症心理健康问题的盛行率增加。在预测期内,这预计将扩大产品应用范围并推动整体市场成长。例如,老年痴呆症失智症的盛行率随着年龄的增长而增加,在美国, 65岁至74岁的人中有5.0%,75岁至84岁的人有13.1%,85岁及以上的人有33.3%。
此外,近年来,消费者的偏好已转向含有抹茶、咖啡因、甜菜根、菠菜、婆罗米、北极根、姜黄、人参和松树皮等成分的草药保健产品。此外,美国素食者数量的不断增加预计将增加对草药产品的需求。
此外,该地区的营养保健品和天然补充剂行业已经很成熟,很可能在预测期内促进高速成长。例如,2020 年美国膳食补充剂的总销售额预计为 557 亿美元,其中含有维生素、矿物质或两者兼有的补充剂的销售额为 212 亿美元,复合综合维他命/矿物质(MVM) 的销售额为80 亿综合维他命。
此外,焦虑、压力和忧郁症等心理健康问题的普遍存在也支持了该行业的成长。例如,美国焦虑和忧郁症协会估计有 680 万美国成年人患有整体焦虑症 (GAD)。
此外,社群媒体平台对消费者决策的影响力也越来越大。此外,随着越来越多的人意识到透过提供宅配、现金回馈、折扣和广泛支付选项的线上药局网站和应用程式来获得认知功能补充剂是多么容易,该市场也在不断增长。非专利补充剂可透过处方笺和非处方药 (OTC) 轻鬆取得,通常用于缓解与认知障碍相关的疼痛。此外,越来越多的运动员在各种竞技运动中使用认知功能补充剂也促进了积极的市场趋势。
为什么要购买这份报告?
它有什么用?
产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响
The Global cognition supplements market is predicted to expand at a CAGR of 13.79% to account for US$27.43 billion by 2030 from US$14.81 billion in 2025.
These Nootropics, or cognitive supplements, claim to improve memory, attention, and brain function in general. Caffeine, Ginkgo biloba, Bacopa monnieri, and omega-3 fatty acids are common components.
The need for cognitive health solutions among ageing populations hoping to preserve mental sharpness is driving the cognition supplements market. The market's growth is further aided by rising stress levels, hectic lifestyles, and the incidence of cognitive illnesses like Alzheimer's disease. Research demonstrating the effectiveness of certain substances and technological developments also contribute to market expansion. Furthermore, as individuals place a higher priority on general brain health and cognitive ability, the trend towards preventative healthcare and self-care rising demand for cognition supplements.
As per the World Health Organization, the population worldwide is rapidly ageing. One billion people worldwide were sixty years of age or older in 2020. By 2030, that number will have increased to 1.4 billion, or one in six persons on the planet. Furthermore, the population of those 60 and over will have doubled to 2.1 billion by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will triple, reaching 426 million.
Furthermore, to meet changing consumer preferences, market players in the cognition supplements industry use a variety of strategies, including investing in research for innovative formulations, forming strategic partnerships for wider distribution, and utilising branding and marketing techniques to differentiate their products and win over customers.
Additionally, based on clinical and scientific evidence, Probi(R) Sensia is a novel probiotic idea that enhances mood and sleep quality, improves working memory and learning, and promotes enhanced cognition. These brain processes are crucial for improving people's general mental well-being. The new probiotic solution is tailored with local assistance, available to suit a range of consumer demands, and backed by claims relevant to global health.
Comprehensively, the cognitive supplements market is expanding significantly due to reasons such as an ageing population, growing awareness of cognitive health, and a rise in demand for performance-enhancing products. Market participants are using a variety of tactics, including branding campaigns, strategic alliances, and research and development, to remain competitive in this ever-changing environment. Furthermore, the cognitive supplements market is expected to grow in the future due to shifting consumer preferences and the ability to create more potent formulations made possible by technological advancements.
Global cognition supplements market drivers
The cognitive supplements market is predicted to be significantly driven by the projected increase in mental health disorders. Complementary and alternative methods to enhance mental well-being are in greater demand due to the rising global prevalence of illnesses including anxiety, depression, and ADHD. Supplements claiming to elevate mood, lessen stress, and increase cognitive function are called cognition supplements, and they are positioned to meet this need. The cognitive supplements market is expected to increase significantly in the upcoming years as people look for ways to prevent and treat mental health concerns. This presents potential for innovation and growth in the industry.
An estimated 57.8 million people in the US who were 18 years of age or older had AMI in 2021. This figure accounted for 22.8% of all adult Americans. Women had a greater frequency of AMI (27.2%) than did men (18.1%). The frequency of AMI was highest in young people (18-25 years old) (33.7%), followed by adults (26-49 years old; 28.1%) and older individuals (15.0%).
Adults reporting two or more racial identities had the highest frequency of AMI (34.9%), followed by those who identified as American Indian or Alaskan Native (AI/AN) (26.6%). Asian adults had the lowest frequency of AMI (16.4%).
Additionally, the National Mental Health Programme (NMHP) is being implemented in India by the government to provide accessible and reasonably priced mental healthcare facilities. The National Health Mission offers support to States and UTs for the District Mental Health Programme (DMHP), a component of the NMHP, which has been approved for implementation in 704 districts. The DMHP provides outpatient services, assessment, counselling, psycho-social interventions, ongoing care and support for individuals with severe mental disorders, medication, outreach services, ambulance services, and other services at the Community Health Centre (CHC) and Primary Health Centre (PHC) levels.
Furthermore, self-reported mental and behavioural disorders are among the many health problems covered by the Australian Bureau of Statistics (ABS) 2020-21 National Health Survey. Only when an individual states that a mental or behavioural condition has lasted, or was anticipated to last, six months or more does the NHS record the individual as having a mental or behavioural condition during the collection period. A mental or behavioural disorder was estimated to have affected 1 in 5 (20%) Australians aged 15 and older during the collecting period (August 2020 to June 2021), according to the 2020-21 NHS (ABS 2022b).
Global cognition supplements market Geographical outlooks
The ageing population is one of the primary causes of dementia and cognitive impairment. The number of elderly people in the United States has been steadily increasing, which has led to an increase in the prevalence of mental health conditions like dementia. Throughout the forecast period, this is expected to expand the product's application scope and boost overall market growth. For instance, the prevalence of Alzheimer's dementia rises with age: 5.0% of those 65 to 74, 13.1% of those 75 to 84, and 33.3% of those 85 years of age and above have the disease in the United States.
Further, consumer preferences have shifted in favour of herbal health products that contain ingredients like matcha tea, caffeine, beets, spinach, Brahmi, Arctic root, turmeric, ginseng, and pine bark in the last few years. Furthermore, it is anticipated that the growing vegan population in the United States will increase demand for herbal products.
Moreover, the dietary and natural supplement industries in this region are well-established, which will contribute to their high growth during the forecast period. For instance, it was projected that the total sales of dietary supplements in the United States in 2020 would be $55.7 billion, $21.2 billion were attributed to supplements that contain vitamins, minerals, or both, with $8.0 billion going toward multivitamins/minerals (MVM) and multivitamins (MVs).
Furthermore, the growing prevalence of mental health issues like anxiety, stress, and depression is supporting the industry's growth. For instance, the Anxiety and Depression Association of America estimates that 6.8 million adult Americans have general anxiety disorder, or GAD.
Further, social media platforms are becoming increasingly influential in consumer decision-making. In addition, the market is expanding as more people become aware of how simple it is to get cognitive supplements through online pharmacy websites and applications that offer home delivery, cashback, discounts, and a plethora of payment options. Typically, they involve generic supplements that are easily obtained by prescription or over-the-counter (OTC) to relieve pain related to cognitive disorders. Positive market trends are also being produced by athletes' increasing use of cognitive supplements for a variety of competitive sports.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence